Saptarshi Sinha

PARP inhibitor Veliparib (ABT-888) enhances the anti-angiogenic potentiality of Curcumin through deregulation of NECTIN-4 in oral cancer: Role of nitric oxide (NO)

Subhajit Chatterjee, Saptarshi Sinha, Sefinew Molla et al. · Cellular Signalling · 2020 · 48 citations

Oncology, Parp Inhibitor Veliparib, Nitric Oxide +11

Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway

Rajalaxmi Pradhan, Subarno Paul, Biswajit Das et al. · The Journal of Nutritional Biochemistry · 2022 · 44 citations

Inflammation, Inflammatory Cytokines, Oncology +10

Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through IL-6/JAK2/STAT3 signaling axis

Rajalaxmi Pradhan, Subarno Paul, S. Acharya et al. · The Journal of Nutritional Biochemistry · 2024 · 31 citations

Oral Cancer Cells, Medicine, Immunology +6

Use of substitute Nonidet P-40 nonionic detergents in intracellular tubulin polymerization assays for screening of microtubule targeting agents

Saptarshi Sinha, Jessica J. Field, John H. Miller · Biochemistry and Cell Biology · 2017 · 26 citations · Full text

Medicinal Chemistry, Available Substitutes, Polymer-drug Conjugate +14

Olaparib enhances the Resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathway

Saptarshi Sinha, Subhajit Chatterjee, Subarno Paul et al. · Experimental Cell Research · 2022 · 26 citations

Breast Oncology, Oncology, Chemoprevention Strategy +11